Pharmacokinetic profiling to understand differences in biological activity of two novel liver-selective NO-releasing compounds V-PYRRO/NO and V-PROLI/NO in the treatment of experimental model of NAFLD in mice

2013/11/N/NZ7/00749

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Kamil Krzysztof Kuś

Number of co-investigators in the project: 3

Call

PRELUDIUM 6 – announced on 2013-09-16

Amount awarded
99 985 PLN
Project start date
2014-07-23
Project end date
2016-11-22
Project duration
28 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Komputer mobilny. Cost: 4 500 PLN

Information in the final report

Publication in academic press/journals (2)

  1. Hepatoselective NO-donors, V-PYRRO/NO and V-PROLI/NO in Nonalcoholic Fatty Liver Disease: a Comparison of Anti-Steatotic Effects with the Biotransformation and Pharmacokinetics

    Authors:
    Kamil Kus, Maria Walczak, Edyta Maslak, Agnieszka Zakrzewska, Anna Gonciarz-Dytman, Piotr Zabielski, Barbara Sitek, Krystyna Wandzel, Agnieszka Kij, Adrian Chabowski, Ryan J Holland, Joseph E Saavedra, Larry K Keefer, Stefan Chlopicki
    Academic press:
    Drug Metabolism and Disposition (year: 2015, volume: 43, pages: 1028-1036), Publisher: American Society for Pharmacology and Experimental Therapeutics
    Status:
    Published
    DOI:
    10.1124/dmd.115.063388 – link to the publication
  2. Differential effects of liver steatosis on pharmacokinetic profile of two closely related hepatoselective NO-donors; V-PYRRO/NO and V-PROLINO

    Authors:
    K. Kus, E. Kus, A. Zakrzewska , W. Jawien, B. Sitek, M. Walczak, S. Chlopicki
    Academic press:
    Pharmacological Reports (year: 2017, volume: 69, pages: 560-565), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharep.2017.01.031 – link to the publication

Articles in post-conference publications (4)

  1. Development of targeted metabolomic profiling of endothelium by LC/MS/MS: A tool to understand endothelial cell metabolism

    Authors:
    Kuś K., Kaczara P., Walczak M., Chlopicki S.
    Conference:
    VII JCET SEMINAR (year: 2016, pages: 28), Publisher: JMRC
    Date:
    conference 19-21.06.2016
    Status:
    Published
  2. Ocena wpływu stłuszczenia wątroby na profil farmakokinetyczny dwóch hepatoselektywnych NO-donorów V-PYRRO/NO oraz V-PROLI/NO

    Authors:
    Kuś K., Walczak M., Maślak E., Zakrzewska A., Keefer L.K., Chłopicki S.
    Conference:
    V Konferencja Doktorantów Uniwersytetu Jagiellońskiego - Collegium Medicum (year: 2015, pages: xxx), Publisher: Zeszyty Naukowe Towarzystwa Doktorantów Uniwersytetu Jagiellońskiego
    Date:
    conference 28-29.05.2015
    Status:
    Published
  3. Comprehensive pharmacokinetic analysis of two liver-selective NO-donors; a key to understand differences in their pharmacological efficacy against NAFLD

    Authors:
    Kuś K., Walczak M., Maślak E., Zakrzewska A., Keefer L., Chłopicki S
    Conference:
    Obesity and the Metabolic Syndrome: Mitochondria and Energy Expenditure (year: 2015, pages: X8 2022), Publisher: Keystone Symposia
    Date:
    conference 22-27.03
    Status:
    Published
  4. Development of LC/MS/MS based targeted metabolomic method to study the effect of carbon monoxide and nitric oxide on endothelial cell metabolism

    Authors:
    Kus K., Kaczara P., Walczak M., Chlopicki S.
    Conference:
    19th International Vascular Biology Meeting (year: 2016, pages: T119), Publisher: NAVBO
    Date:
    conference 30.10-03.11.2016
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski